Under the terms of the agreement, Osteotech noted that CTS will supply the company with a specific number of whole donors and cortical shafts on a monthly basis based upon periodic forecast requirements and available tissue supply. This new agreement expires in December 2019 and includes one 5-year renewal term and subsequent 2-year renewal terms, subject to six month cancellation clauses.

Osteotech is a provider of biologic solutions for regenerative medicine to support surgeons and their patients through the development of therapy-driven products.